CUSIP 52886N406COM NEWLEXXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
21 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Invenomic Capital Management LP | 470.9K | $290.6K | −6.3K | Reduced |
| 2 | Ubs Group AG | 361.3K | $222.9K | +354.2K | Added |
| 3 | Vanguard Group Inc | 258.8K | $159.7K | 0 | Held |
| 4 | Geode Capital Management, LLC | 219.7K | $135.6K |
| +44.9K |
| Added |
| 5 | Toronto Dominion Bank | 140.0K | $86.5K | 0 | Held |
| 6 | Byrne Asset Management LLC | 105.5K | $65.1K | +74.2K | Added |
| 7 | State Street Corp | 39.3K | $24.2K | 0 | Held |
| 8 | Blackrock, Inc. | 27.4K | $16.9K | 0 | Held |
| 9 | Krilogy Financial LLC | 19.7K | $16.0K | 0 | Held |
| 10 | Northern Trust Corp | 18.4K | $11.3K | 0 | Held |
See every fund holding Lexaria Bioscience Corp, with full quarter-over-quarter share changes.
Unlock all holders